* Jaguar Health Inc JAGX.OQ reported a quarterly adjusted
loss
of 7 cents per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 3 cents per
share.
* Revenue was $2.35 million; analysts expected $2.96
million.
* Jaguar Health Inc's reported EPS for the quarter was a
loss of 6
cents.
* The company reported a quarterly loss of $9.23 million.
* Jaguar Health Inc shares had risen by 222.9% this
quarter and
gained 91.7% so far this year.
FORECAST CHANGES
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
*
* Wall Street's median 12-month price target for Jaguar
Health Inc
is $0.60
This summary was machine generated from LSEG data May 14 at
03:49 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.03 -0.07 Missed
Sep. 30 2023 -1.23 -0.55 Beat
Jun. 30 2023 -1.53 -0.69 Beat